Indus Holdings, Inc. Reports Record Third Quarter 2020 Results
Company delivers strong results despite being adversely affected by California Wildfires
See the rest here:
Indus Holdings, Inc. Reports Record Third Quarter 2020 Results
Category Archives: Global News Feed
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
- Firdapse® Third Quarter Net Revenues of $29.2 Million
See the original post:
Catalyst Pharmaceuticals Announces Third Quarter 2020 Financial Results and Provides Business Update
Supernus Provides Regulatory Updates for SPN-812 and SPN-830
ROCKVILLE, Md., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a pharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced regulatory updates for SPN-812 (viloxazine hydrochloride) for the treatment of attention-deficit hyperactivity disorder (ADHD) in pediatric patients 6 to 17 years of age, and SPN-830 (apomorphine infusion pump) for the continuous treatment of motor fluctuations (“on-off” episodes) in Parkinson’s disease (PD).
Read more from the original source:
Supernus Provides Regulatory Updates for SPN-812 and SPN-830
Indus Holdings, Inc. Announces New Chief Financial Officer
Board Member Brian Shure will join executive team as Chief Financial OfficerSteve Neil will remain at the Company in a senior capacity
Read the rest here:
Indus Holdings, Inc. Announces New Chief Financial Officer
Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
CAMBRIDGE, Mass., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system disorders characterized by neuronal imbalance, today announced that it has received a response from the U.S. Food and Drug Administration (FDA) on the Investigational New Drug (IND) submission for PRAX-114 for the treatment of major depressive disorder (MDD).
Excerpt from:
Praxis Precision Medicines Provides Regulatory Update On PRAX-114 Program
Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
MALVERN, Pa., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (Nasdaq: GRTX), a clinical-stage biopharmaceutical company focused on developing and commercializing a pipeline of novel, proprietary therapeutics that have the potential to transform radiotherapy in cancer, today announced that Mel Sorensen, M.D., President and Chief Executive Officer, will present at the 29th Annual Credit Suisse Virtual Healthcare Conference on Tuesday, November 10, 2020, at 11:45 a.m. ET.
Excerpt from:
Galera Therapeutics to Present at the 29th Annual Credit Suisse Virtual Healthcare Conference
Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management
FORT LAUDERDALE, Fla., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) ("Motus GI" or the "Company"), a medical technology company providing endoscopy solutions to help improve clinical outcomes, is launching a new clinical protocol with NYU Langone Health to incorporate the Company’s Pure-Vu® GEN2 System (Pure-Vu) with the intention to improve the management of its inpatient colonoscopies.
See the original post:
Motus GI and NYU Langone Health Partner to Improve its Inpatient Colonoscopy Management
Altimmune to Announce Third Quarter 2020 Financial Results on November 10
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will release its third quarter 2020 financial results on Tuesday, November 10, 2020.
Read more:
Altimmune to Announce Third Quarter 2020 Financial Results on November 10
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Catalyst Biosciences, Inc. (NASDAQ: CBIO) today announced that Nassim Usman, Ph.D., president and chief executive officer, and Clinton Musil, chief financial officer, of Catalyst Biosciences will present at the Stifel 2020 Virtual Healthcare Conference taking place on November 16-18, 2020. Details for the company presentation are as follows:
Read more from the original source:
Catalyst Biosciences to Present at Stifel 2020 Virtual Healthcare Conference
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020
GAITHERSBURG, Md., Nov. 03, 2020 (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its third quarter 2020 financial and operating results following the close of U.S. financial markets on Monday, November 9, 2020.
Read this article:
Novavax to Host Conference Call to Discuss Third Quarter Financial and Operating Results on November 9, 2020